POMDOCTOR Ltd
corporate_fare Company Profile
POMDOCTOR Ltd (NASDAQ:POM) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 17 items for POM at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-19, rated 7/10. Across its 17 most recent items scored 7 or higher, the top rating is 9/10, with 10 rated 8 or above. Recent SEC coverage for POM spans 6-K, 20-F.
Recent high-impact activity:
- PomDoctor Begins ADR Termination; Ordinary Shares to Trade on Nasdaq Oct 21 After 10:1 Consolidation
- Nasdaq Moves to Delist PomDoctor After Compliance Lapse
- POMDOCTOR Shareholders Approve ADR Termination and 10-to-1 Reverse Split
- POMDOCTOR Flags Going Concern Doubt After RMB238M H1 Loss
- POMDOCTOR Unveils US$30M Capital Raise Plan Ahead of H.C. Wainwright Conference
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 22,500 shares in POM as of the October 15, 2026 settlement, a 13.3% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On October 30, 2026, 47.3% of POM volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Insider Transactions
POM files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.